Venus Concept Inc (VERO) 2023 Q4 法說會逐字稿

Please stand by.

Good day, ladies and gentlemen, and welcome to the fourth-quarter 2023 earnings conference call for Venus Concept Inc. (Operator Instructions) Please note that this conference call is being recorded, and that the recording will be available on the company's website for replay.

Before we begin, I would like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including those identified in the Risk Factors section of our most recent 10-Q, and our annual report on Form 10-K, filed with the Securities and Exchange Commission.

Such factors may be updated from time to time in our filings with the SEC, which are available on our website.

We undertake no obligation to publicly update or revise our forward-looking statements as a result of new information, future events, or otherwise.

This call will also include references to certain financial measures that are not calculated in accordance with the generally accepted accounting principles, or GAAP.

We generally refer to these as non-GAAP financial measures.

Reconciliations of those non-GAAP financial measures to the most comparable measures calculated and presented in accordance with GAAP are available in our earnings press release issued today on the Investor Relations portion of our website.

I would now like to turn the call over to Mr. Rajiv De Silva, Chief Executive Officer of Venus Concept.

Please go ahead, sir.

Thank you, operator, and welcome, everyone, to Venus Concept's fourth-quarter 2023 earnings conference call.

I'm joined on the call today by our Chief Financial Officer, Domenic Della Penna, and by our President and Chief Operating Officer, Dr. Hemanth Varghese.

Let me start with an agenda of what we will cover during our prepared remarks.

I will begin with a brief overview of our Q4 2023 results and notable operating developments in the recent months.

Then, Hemanth will share an update on our progress in several key initiatives of our corporate turnaround strategy.

Domenic will then provide you with an in-depth review of our fourth-quarter financial results and our balance sheet and financial condition at year end, as well as a review of our Q1 2024 financial outlook outlined in today's press release.

Then we will open the call for your questions.

With that agenda in mind, let's get started.

As you would have seen in our press release issued today, we are pleased that we achieved our primary goal of reducing cash burn by more than 50% in 2023.

Key elements of our transformation strategy, cost reductions, shift to cash sales, and working capital management, all contributed to this achievement.

I'm proud of the resilience shown by our organization in navigating through a difficult year of transition.

In the fourth quarter of 2023, we delivered total revenue of $18.1 million, down $6.2 million or 25% year over year, and up $0.5 million or 3%, quarter over quarter.

Our fourth-quarter revenue results reflect softer-than-expected system sales in the US due to macroeconomic conditions, and tighter credit markets, and by the impacts of our accelerated restructuring activities in certain international markets.

Similar to what we discussed on our recent earnings calls, macroeconomic headwinds continue to pressure the aesthetics sector as a whole, while higher interest rates affecting our customers' ability to finance new capital equipment purchases, and deals are taking much longer to close.

Our revenue results outside the US continued to be impacted by the strategic initiatives we executed last year.

Specifically, we are transitioning the company to higher-quality cash revenues, exiting unprofitable direct operations in certain international markets, and implementing a series of restructuring activities, which all together are expected to enhance the cash flow profile of the business and accelerate the path to long-term sustainable profitability and growth.

We are pleased with the progress we have made in our strategic turnaround plan in 2023.

Despite the continuing challenging operating environment, we remain encouraged by the signs that our efforts to reposition the business and to focus on key strategic and operational initiatives are well founded.

First, we are pleased to report that cash system sales represented 67% of total systems and subscription sales for fiscal year 2023 compared to 58% in fiscal year 2022.

Our progress on this initiative is even more evident when looking at the mix of cash system sales in the US, which represented 71% of total US systems and subscription sales in fiscal year 2023 compared to 53% in the prior year period.

Cash system sales to US customers increased 11% year over year in 2023, which reflects the team's strong execution towards our strategic priority to transition the company to higher quality cash revenues.

Second, our restructuring activities in certain international markets have resulted in headwinds to our growth trends as expected.

By way of reminder, one of our key strategic priorities in 2023 was to optimize our commercial and operational strategy in certain international markets, and to reinvest those resources in high opportunity markets to enhance the company's longer-term growth and profitability profile.

Our restructuring activities outside the US have included winding down direct operations in smaller and less profitable markets and transitioning to partner with distributors, with a target of having our new distributor partners in key markets identified, signed up, and up and running in the majority of our key international markets by early 2024.

With that, we expect to be well positioned for a return to growth in our key international markets this year.

Finally, while the macroeconomic environment represented more of a headwind than we had contemplated, our team is executing well despite these unexpected challenges.

As I mentioned, importantly, the company achieved its primary strategic objective for 2023 to reduce cash used in operations by more than 50%.

Specifically, our team's strong execution towards the strategic objective resulted in a 52% reduction in cash used in operations in 2023.

We believe that this represents the clearest evidence that we are on the right track towards our goal of enhancing the cash flow profile of the business and accelerating the path to long-term sustainable profitability and growth.

Two other noteworthy items I wanted to briefly discuss.

On March 25, we announced that we received a decision from the Nasdaq Hearings Panel granting our request for continued listing on the Nasdaq Capital Market, subject to the company demonstrating compliance with Nasdaq Listing Rule 5550(b) on or before May 28, 2024, and certain other conditions.

We also announced on January 24 that the company's Board of Directors have authorized the exploration of strategic options for the company.

This effort, focused on maximizing value for all stakeholders, is currently underway.

As part of this effort, the company is engaging with its lenders and existing shareholders as well as with external parties to explore avenues to improve the financial profile of the company, with a view to longer-term value creation.

We look forward to providing an update on this initiative at the appropriate time.

I would now like to turn the call over to Dr. Hemanth Varghese, who will share an update on recent progress in our restructuring programs, new product pipeline initiatives, and our recent company-wide rebranding initiative, which marked an important inflection point in our strategic turnaround.

Hemanth?

Thanks, Rajiv.

As discussed on our last earnings call, we've made considerable progress against several key initiatives of our corporate turnaround strategy.

Let me share a little color where we're making notable progress.

First, our cost reduction and cash management initiatives designed to accelerate our path to cash flow breakeven are progressing at, or ahead, of expectations.

The targeted incremental cost containment initiatives, implemented in the second half of the year, has helped to protect our near-term cash runway.

Second, our efforts to rationalize our international infrastructure, reduce costs, and simplify the organization are progressing well, as we endeavor to establish the optimal mix of direct presence and distribution partners in key international markets around the world.

Discussions are ongoing with existing and several new distribution partners to align with our new international strategy.

We were pleased to announce the expansion of our international distribution network in December with the signing of two new exclusive partnerships in the United Kingdom and India.

Multiple new distribution agreements are under negotiation, which has us on track to be essentially complete with our international repositioning and ready to return to growth outside the US in 2024.

Fourth, our efforts to advance certain new product pipeline projects are ahead of expectations, resulting in strong momentum on new product introductions in recent months.

After receiving 510(k) clearance in September, we were pleased to announce the US commercial launch of our new multi-application platform, the Venus Versa Pro, on November 1.

We were pleased to announce CE mark from DEKRA Certification BV to market the Venus Versa Pro system in the European Union on February 22.

Finally, we're very excited with the early feedback from our company-wide rebranding initiative last October.

As discussed on our last earnings call, Venus Aesthetic Intelligence, or Venus AI, captures our strong commitment towards growing our global brand, focusing on emerging technologies and services and partnering with customers to build smarter practices and customizable treatments.

We want our customers to know that we are not just a product innovation company.

Rather, we want to deliver more than leading device performance.

We're focused on delivering total practice performance, from the moment the patient enters the clinic to post treatment recovery.

Further, by staying connected to our customers, we can start to leverage real-time data across our growing network of connected devices to uncover the meaningful business insights that define the best-in-practice performance and fuel the next generation of aesthetic device technologies.

To that end, we were excited to announce the NEXThetics program in March.

NEXThetics is a new series of customer education and training events launched under our Venus AI rebrand.

The NEXThetics program represents a great example of how we are enhancing our focus on physician education and practice enhancement by empowering professionals in the field of aesthetics with knowledge, tools, and support that they need to grow their businesses.

With that, let me turn the call over to Domenic for a review of our fourth-quarter financial results and balance sheet as of year-end 2023.

Domenic?

Thank you, Hemanth.

For the avoidance of doubt, unless otherwise noted, my prepared remarks will focus on the company's reported results for the fourth quarter of 2023 on a GAAP basis, and all growth-related items are on a year-over-year basis.

We reported total revenue of $18.1 million, down $6.1 million or 25% year over year.

The decrease in total revenue by region was driven by a 40% decrease year over year in international revenue, and a 14% decrease year over year in United States revenue.

Our international business was impacted by the company's decision to exit three unprofitable direct markets in the past year, as well as general macroeconomic headwinds that impacted customer access to capital.

The decrease in total revenue by product category was driven by a 38% decrease in products' systems revenue and a 30% decrease in products' other revenue, partially offset by a 5% increase in lease revenue and a 4% increase in services revenue.

The percentage of total systems revenue derived from the company's subscription model was approximately 41% in the fourth quarter of 2023 compared to 29% in the prior year period and 31% in the third quarter of 2023.

Turning to a review of our fourth-quarter financial results across the rest of the P&L, gross profit decreased $3.7 million, or 24%, to $12.1 million.

The change in gross profit was primarily due to a decrease in revenue in our international markets, driven by the accelerated exit from unprofitable direct markets.

Gross margin was 66.5% of revenue compared to 65% of revenue for the fourth quarter of 2022.

The change in gross margin was primarily due to improved margin management and reduced inventory write-offs when compared to the previous period.

Total operating expenses decreased $5 million, or 20%, to $19.7 million.

The change in total operating expenses was driven primarily by a decrease of $2.7 million or 21% in general and administrative expenses, a decrease of $1.4 million or 15% in selling and marketing expenses, and a decrease of $0.9 million or 35% in research and development expenses.

Fourth quarter of 2023 GAAP general and administrative expenses include approximately $0.3 million of costs related to restructuring activities designed to improve the company's operations and cost structure.

The total operating loss was $7.6 million compared to operating loss of $8.9 million for the fourth quarter of 2022.

Net interest and other expenses were $3.7 million compared to $1.9 million in the fourth quarter of 2022.

The year-over-year change in net interest and other expenses was driven primarily by a $2 million loss on debt extinguishment and higher interest expense offset partially by reductions in both non-cash foreign exchange loss and a loss on disposal of subsidiaries, compared to the prior year period.

Net loss attributable to stockholders for the fourth quarter of 2023 was $11.1 million, or $2.01 per share compared to net loss of $9.9 million or $2.11 per share for the fourth quarter of 2022.

Adjusted EBITDA loss for the fourth quarter of 2023 improved 7% year over year to $5.9 million, compared to adjusted EBITDA loss of $6.3 million for the fourth quarter of 2022.

As a reminder, we have provided a full reconciliation of our GAAP net loss to adjusted EBITDA loss in our earnings press release.

Turning to the balance sheet, as of December 31, 2023, the company had cash and cash equivalents of $5.4 million and total debt obligations of approximately $74.9 million compared to $11.6 million and $77.7 million, respectively, as of December 31, 2022.

Cash used in operations for the three months ended December 31 was $0.8 million, a 77% decrease in cash used year over year and an 81% decrease in cash used quarter over quarter.

The year-over-year and sequential decrease in cash used in operations was driven primarily by strong working capital performance, with more than $5.5 million of cash generated from working capital in the period.

Cash used in operating and investing activities during the fourth quarter of 2023 was partially offset by $1.3 million of cash from financing activities in the period, driven by the net proceeds of $1.8 million from the sale of senior preferred stock from the fourth tranche in the 2023 multi-tranche private placement, which occurred on October 20, 2023.

Turning to a review of our financial outlook for 2024, as outlined in our press release, given the company's active dialogue with existing lenders and investors, and the ongoing evaluation of strategic alternatives with various interested parties to maximize shareholder value, the company is not providing full-year 2024 financial guidance at this time.

The company expects total revenue for the three months ending March 31, 2024, of at least $16.5 million.

With that, I'll turn the call over to the operator to open the call for your questions.

Operator?

(Operator Instructions) Marie Thibault, BTIG.

Hi.

Thanks for taking the question.

Wanted to ask a question here about the Q1 outlook as well as the OUS outlook.

For Q1, what is being included in that forecast in terms of kind of macroenvironmental pressures?

Your OUS and US assumptions, if you can just give us more detailed picture of what went into that outlook?

Sure.

Marie, let me start.

I'll have Domenic add to it.

Look, as you can imagine, the first quarter is over, right?

And the only uncertainty at this point is revenue recognition.

So we've built some conservatism into that number to reflect the fact that we still need to go through revenue recognition procedures.

But what I would say is that we are encouraged by what we are seeing in international markets in the first quarter, in that we are seeing our new distributors placing orders.

We have also seen a pickup in our hair business outside the US.

So all early indicators that return to growth for 2024 is something that we can certainly aspire to, depending on how the year -- the remainder of the year goes in international markets.

In the US, we continue to see the macroeconomic headwinds that we saw in the fourth quarter.

And certainly in terms of -- we'll be obviously not giving guidance for the full year at this point given our strategic process.

But we know we would not expect to see an improvement in the US environment, at least until the second half of the year.

Okay.

That's very helpful.

And then is there anything you can tell us on the evaluation of strategic options, in terms of ideas or the options that are being narrowed down?

Anything on timeline and also how you're managing cash flow in the meantime?

Thanks for taking the questions.

Sure.

Again, I'll start.

I want to hand it over to Domenic to talk about the cash management part of the question.

Look, the strategic evaluation process is ongoing.

That's probably the only concrete statement I can make, as you can imagine, with these types of processes.

Until you come to some conclusion, it's difficult to provide interim updates.

But I will say the following, which is that this is a process that includes multiple initiatives.

One obviously is around working with our lenders to explore the pathways to increase -- improve the company's financial profile.

We're talking with existing shareholders, but also with a series of external parties who have expressed some interest in the company.

And those discussions are ongoing.

It is certainly not a process where we can conclude that there's a definitive outcome yet, but I'm encouraged by the progress we're making, and I am hopeful that we should be able to make at least a progress update in the coming months in the second quarter.

And on the cash management topic, before I turn this over to Domenic, we are acutely focused on maintaining and improving the company's liquidity profile, and that clearly is a big part of our strategic initiative as well.

And as you probably saw, we were able to do a small RDO this quarter to bring a little bit of cash in, and we continue to look for ways to enhance our cash profile.

And we are also encouraged by the mix of cash versus subscription sales in the first quarter, which has also been helpful.

So with that, Domenic, let me just see if you want to add anything else to the cash question?

Sure.

I think where you saw in the fourth quarter, we continue to reduce our burn; we expect to continue that throughout all of 2024.

The first quarter is a bit challenging because we've had very heavy expenses in relation to being a public company in the first quarter.

But I think year on year, we'll demonstrate some decent results.

But we're going to continue to focus on improving our overall cash burn in 2024, along the same lines of what we did in 2023.

The other thing I will point out is that, in relation to your earlier question, in terms of international versus US business in Q1, there are very many challenges that remain in the US, but we actually had a fairly good outcome quarter over quarter this year compared to last year in the US.

So we're starting to see signs where it's certainly pointed in the right direction.

International as well, having signed up distributors, we expect that to benefit us in the second half of the year, in particular.

But we are encouraged by what we saw in the US in terms of performance.

Notwithstanding some of the headwinds that we had, we had a better overall performance, I would say, in the US than what we had in Q4.

Thank you.

(Operator Instructions) Jeffrey Cohen, Ladenburg.

So hey, good morning.

A couple of questions from [us], if you don't mind.

One, could you talk about Aime and timelines and anticipated launches, et cetera, for this year?

And then secondly, could you talk a little bit about the hair business and any trends there over the past few quarters you've experienced?

Thank you.

Thanks.

Hemanth, do you want to field those two questions?

With respect to Aime, as we have discussed, we continue to be pretty excited about what we're going to be able to do with Aime and the opportunity.

With the management we've been doing on cash, increasing of R&D investments, we have prioritized the energy-based products in the early part of this year, like Versa Pro that we'd mentioned and the body system that we're targeting for 2024.

And so Aime launch at this time, at best, would be back end of the year or into 2025, in terms of potential time.

It is one we want to make sure we do correctly.

So we're spending the time to make sure we've gotten everything straight.

And the hair business, Hemanth?

That's the next part of the question.

Hair business as a whole, I will say Q4 was a little tougher, again, with macroeconomic environments.

Our hair business, especially our ARTAS robot, being probably the most expensive of our systems, gets most affected by the tough financing environment.

But as Domenic had mentioned, we are seeing some strong turnaround type trends in 2024.

And I think when we ultimately report on Q1, hair business rebound to '24 outlook looks strong as well.

Perfect.

Thanks for taking our questions.

(Operator Instructions) We are currently showing no additional participants in queue.

This does conclude our conference for today.

Thank you for your participation.